We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Urinary Metabolites Are Different in Autistic Children

By HospiMedica International staff writers
Posted on 15 Jun 2010
A simple urine test is under development to diagnose children with autism.

People with autism also often suffer from gastrointestinal disorders and have a different makeup of bacteria in their guts from nonautistic people.

It is possible to distinguish between autistic and nonautistic children by looking at the by-products of gut bacteria and the body's metabolic processes in the children's urine. More...
The exact biological significance of gastrointestinal disorders in the development of autism is unknown.

In a recent study, carried out by Anglo-Australian scientists, the chemical composition of the urine of three groups of children aged between 3 and 9 was investigated. The three groups were composed of 39 children who had previously been diagnosed with autism, 28 nonautistic siblings of children with autism, and 34 children who did not have autism and did not have an autistic sibling. The urines were analyzed by nuclear magnetic resonance spectroscopy (1H-NMR), which can identify chemical molecules. Each of the three groups had a distinct chemical fingerprint, and autistic children had a different chemical fingerprint than the other two groups. Autistic children, for example, showed increased urinary excretion of nicotinic acid, high levels of urinary taurine and low levels of urinary glutamate. These biochemical changes are consistent with some of the known abnormalities of gut microbiota found in autistic individuals and the associated gastrointestinal dysfunction and may be of value in monitoring the success of therapeutic interventions.

Prof. Jeremy Nicholson, Ph.D. of Imperial College (Imperial College London, London, UK), said, "We know that giving therapy to children with autism when they are very young can make a huge difference to their progress. A urine test might enable professionals to quickly identify children with autism and help them early on." The study was published in June 2010 in the Journal of Proteome Research.

Autism affects an estimated 1 in every 100 people in the UK, and 1 in 166 children in the USA. Assessment for autism is a lengthy process involving a range of tests that explore the child's social interaction, communication, and imaginative skills. It is currently difficult to establish a firm diagnosis when children are less than 18 months of age.

Related Links:
Imperial College London



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.